⚠ LIVE — European Consumer Safety Watch 💊 Medicinsk kanal: 18 Under de senaste 7 dagarna 🍎 kanal.mat.label: 180 Under de senaste 7 dagarna 🧸 Produkter i kanalen: 48 Under de senaste 7 dagarna 🟢 Övervakning: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Senaste hämtning: för 4 timmar sedan ⚠ LIVE — European Consumer Safety Watch 💊 Medicinsk kanal: 18 Under de senaste 7 dagarna 🍎 kanal.mat.label: 180 Under de senaste 7 dagarna 🧸 Produkter i kanalen: 48 Under de senaste 7 dagarna 🟢 Övervakning: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Senaste hämtning: för 4 timmar sedan
🛡️ EUSW
🇸🇪
💊

Spikevax (previously COVID-19 Vaccine Moderna)

COVID-19 mRNA vaccine
COVID-19-infektion
✅ Auktoriserad
Inga aktiva aviseringar
Denna medicin har inga pågående brister, säkerhetsbrev eller återkallelser.

Vad det används till

Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax bivalent Original/Omicron BA.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against COVID-19. The use of this vaccine should be in accordance with official recommendations. Spikevax bivalent Original/Omicron BA.4-5 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax LP.8.1 is indicated for active immunisation to prevent COVID 19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations.

⚠️ Patientsäkerhet

No

⚠️ Vi sammanställer officiella meddelanden. Vi lämnar ingen medicinsk rådgivning. För medicinska eller juridiska beslut, rådfråga den ansvariga myndigheten och en kvalificerad yrkesutövare.